Case Report of Mabwell’s Nectin-4 targeting ADC (9MW2821) in Cervical Cancer Published in The New England Journal of Medicine
SHANGHAI, April 22, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industrial chain, announced that a recent clinical case report on its self-developed novel Nectin-4 ADC (bulumtatug fuvedotin, R&D code: 9MW2821) for the treatment of cervical cancer has been published in The New England Journal of Medicine (NEJM, Impact Factor: 78.5), a leading international medical...
Dawn Medical Technologies Acquires Controlling Interest in Pinnacle Health in Vietnam
Strategic entry into high-growth Vietnam market Combines Dawn's product sourcing capabilities with Pinnacle Health's established local presence and market expertise Advances Dawn's mission to expand access to high-quality, affordable medical technologies across Southeast Asia SINGAPORE and HO CHI MINH CITY, Vietnam, April 22, 2026 /PRNewswire/ -- Dawn Medical Technologies ("Dawn"), CBC Group's MedTech commercialization platform, today announced...
ViGenCell’s VT-EBV-N Selected for Oral Presentation at ASCO 2026
Phase 2 study of EBV-specific T cell therapy to be presented at a leading oncology meeting SEOUL, South Korea, April 22, 2026 /PRNewswire/ -- ViGenCell Inc. (KOSDAQ: 308080), a clinical-stage biotechnology company based in South Korea focused on advanced cell therapies, today announced that results from its Phase 2 clinical study of...
Health In Tech to Present at the Market Movers Investor Summit
STUART, Fla., April 22, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) (the "Company"), an AI-enabled InsurTech platform company, today announced that it will be participating in the Market Movers Investor Summit on Tuesday, May 5, 2026. The Company's presentation, led by Julia Qian, CFO, will take place at 3:00...
Veterans still battling with DVA claims system
Half of younger veterans aged under 50 are avoiding mental health support due to wait times and system complexity 67% of younger veterans experiencing increased stress or anxiety after trying to access support Only four in ten (44%) acknowledge the quality and access to veteran support services has improved since the 2024 Royal Commission into Defence and Veteran...
Dimora Medical Goes Viral on TikTok, as Hydrocolloid Roll Finds New Use in Acne Care
NEW YORK, April 22, 2026 /PRNewswire/ -- Over the past 28 days, Dimora Medical has seen an average daily increase of over 165% in visitors to its TikTok Shop for its hydrocolloid roll, driven by several factors, with a recent creator video emerging as a key source of visibility and interest. Originally designed as a medical-grade wound dressing, the roll...
Suvoda introduces agentic RTSM, cutting clinical trial start-up timelines by up to 80%
Next-generation, AI-powered Randomization and Trial Supply Management system—designed to get studies to first-patient-in significantly faster CONSHOHOCKEN, Pa., April 21, 2026 /PRNewswire/ -- Getting a clinical trial from contract to go-live can take months. For sponsors working to deliver therapies to patients who need them, the startup window is one of the...
Keung To Appointed Official Brand Ambassador for Herbalgy and Touch Cool
KEEP ME UP. HOLD TIGHT. KEEP GOING.Limited-Edition Collectible Keychains Drop NowYour Bag, Your Keys, Your Everyday Download high-resolution images: https://bit.ly/4tw4GyF HONG KONG, April 21, 2026 /PRNewswire/ -- At the intersection of two 27s—Keung To turning 27, and pain management pioneer Herbalgy celebrating its 27th anniversary, a new cultural collision takes shape....
ReviR Therapeutics Receives Strategic Investment from CureCMT to Advance a First-of-its-Kind Precision Medicine Platform for CMT
An isogenic iPSC and AI-enabled disease modeling platform spanning multiple genetically defined CMT subtypes will be established to support patient stratification, accelerate RTX-117 development, and create a shared foundation for next-generation therapies BRISBANE, Calif., April 21, 2026 /PRNewswire/ -- ReviR Therapeutics today announced a strategic investment from CureCMT to support the launch of a precision medicine platform for Charcot-Marie-Tooth...
Insilico Medicine Announces Industry’s First Longevity Board to Accelerate AI-Driven Aging Research for Drug Discovery
CAMBRIDGE, Mass., April 21, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the strategic formation of the industry's first Longevity Board (Board). The initiative provides scientific oversight and strategic guidance for AI-enabled aging research and drug discovery, accelerating the development of therapeutics that target the fundamental biological processes of aging...
